Canopy Growth (CGC) Competitors $1.05 +0.02 (+1.94%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.06 +0.01 (+0.95%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CGC vs. ACB, CRON, OGI, SNDL, TLRY, VFF, STZ, XERS, NUVB, and TRVIShould you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Constellation Brands (STZ), Xeris Biopharma (XERS), Nuvation Bio (NUVB), and Trevi Therapeutics (TRVI). Canopy Growth vs. Its Competitors Aurora Cannabis Cronos Group Organigram Global SNDL Tilray Brands Village Farms International Constellation Brands Xeris Biopharma Nuvation Bio Trevi Therapeutics Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Does the media favor CGC or ACB? In the previous week, Canopy Growth had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.51 beat Aurora Cannabis' score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is CGC or ACB more profitable? Aurora Cannabis has a net margin of 1.32% compared to Canopy Growth's net margin of -195.76%. Aurora Cannabis' return on equity of 0.13% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets Canopy Growth-195.76% -88.54% -40.78% Aurora Cannabis 1.32%0.13%0.10% Do insiders and institutionals hold more shares of CGC or ACB? 3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 1.3% of Canopy Growth shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better valuation and earnings, CGC or ACB? Aurora Cannabis has higher revenue and earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCanopy Growth$225.65M0.95-$429.86M-$4.04-0.26Aurora Cannabis$246.72M1.02$1.63M$0.1140.73 Which has more volatility and risk, CGC or ACB? Canopy Growth has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.84, suggesting that its share price is 84% more volatile than the S&P 500. Do analysts prefer CGC or ACB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 SummaryAurora Cannabis beats Canopy Growth on 13 of the 16 factors compared between the two stocks. Get Canopy Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGC vs. The Competition Export to ExcelMetricCanopy GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$211.30M$10.40B$5.48B$9.51BDividend YieldN/A1.99%4.73%4.09%P/E Ratio-0.2618.4228.6723.80Price / Sales0.9529.01373.9066.58Price / CashN/A22.3135.4557.96Price / Book0.553.478.275.55Net Income-$429.86M$234.77M$3.24B$259.03M7 Day Performance-7.89%-4.82%-3.69%-4.59%1 Month Performance-11.76%1.80%4.33%4.46%1 Year Performance-84.02%-12.51%25.95%18.03% Canopy Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGCCanopy Growth0.6272 of 5 stars$1.05+1.9%N/A-84.5%$211.30M$225.65M-0.263,150News CoverageUpcoming EarningsACBAurora Cannabis0.3762 of 5 stars$4.70+3.8%N/A-26.0%$264.38M$246.72M42.731,130Upcoming EarningsCRONCronos Group2.3244 of 5 stars$2.09+4.0%N/A-17.0%$806.07M$117.61M16.08450Upcoming EarningsOGIOrganigram Global1.1589 of 5 stars$1.46+0.7%N/A-15.3%$195.55M$117.47M14.60860News CoverageSNDLSNDL2.6343 of 5 stars$1.58+2.6%$4.00+153.2%-25.3%$415.19M$671.81M-5.452,516Trending NewsEarnings ReportAnalyst RevisionTLRYTilray Brands2.8903 of 5 stars$0.67+8.4%$1.92+184.6%-71.4%$677.88M$788.94M-0.642,650Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionGap DownVFFVillage Farms International2.7654 of 5 stars$1.38+3.8%N/A+38.7%$155.03M$336.18M-3.831,400Positive NewsSTZConstellation Brands4.6223 of 5 stars$167.96-1.5%$213.74+27.3%-32.2%$29.61B$10.96B-70.2810,600Positive NewsXERSXeris Biopharma3.383 of 5 stars$5.14+0.6%$6.25+21.6%+121.4%$803.79M$203.07M-17.13290News CoveragePositive NewsUpcoming EarningsShort Interest ↑NUVBNuvation Bio2.2856 of 5 stars$2.36+2.4%$7.17+204.3%-37.4%$801.31M$7.87M-1.0060News CoverageUpcoming EarningsTRVITrevi Therapeutics2.4543 of 5 stars$6.82-0.6%$20.88+206.1%+136.5%$799.92MN/A-15.1620News CoveragePositive NewsUpcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies ACB Competitors CRON Competitors OGI Competitors SNDL Competitors TLRY Competitors VFF Competitors STZ Competitors XERS Competitors NUVB Competitors TRVI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Canopy Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.